Fentanyl -- United States
Label
Fentanyl -- United States
Name
Fentanyl
Focus
Sub focus
Actions
Incoming Resources
- Subject of30
- Illicit Fentanyl from China, an evolving global operation, Lauren Greenwood, Congressional fellow, Kevin Fashola, Former Congressional fellow
- Follow the money, the CCP's business model fueling the fentanyl crisis : hearing before the Subcommittee on National Security, Illicit Finance, and International Finance Institutions of the Committee on Financial Services, U.S. House of Representatives, One Hundred Eighteenth Congress, first session, March 23, 2023
- Fueling an epidemic, report four, inside the Insys strategy for boosting fentanyl sales, U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office
- An Act to Amend the Fentanyl Sanctions Act, to Modify Certain Deadlines Relating to the Commission on Combating Synthetic Opioid Trafficking
- Illicit fentanyl and weapons of mass destruction, international controls and policy options, Paul K. Kerr, Liana W. Rosen
- Fiscal year 2024 Department of Health and Human Services budget, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, March 29, 2023
- Understanding a growing crisis, substance use trends among older adults : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighteenth Congress, first session, Washington, DC, October 26, 2023
- Fentanyl analogues, perspectives on classwide scheduling : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Sixteenth Congress, second session, January 28, 2020
- Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States
- Oversight of federal efforts to combat the spread of illicit fentanyl, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, July 16, 2019
- Addressing the supply chain of synthetic drugs in the United States, minority staff policy report, Committee on Homeland Security and Governmental Affairs, United States Senate
- Controlled substances, federal policies and enforcement : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Sixteenth Congress, first session, Thursday, March 11, 2021
- Fact sheet: the President's budget secures our border, combats fentanyl trafficking, and calls on Congress to enact critical immigration reform, The White House
- The silent epidemic, fentanyl and older Americans
- Fentanyl flows from China, an update since 2017, Sean O'Connor
- Synthetic Opioid Danger Awareness Act, report (to accompany H.R. 2364)
- The growing threat of xylazine and its mixture with illicit drugs, DEA joint intelligence report
- Comparison of proposed legislation concerning fentanyl-related substances, Joanna R. Lampe, Lisa N. Sacco
- An Act to Extend the Temporary Scheduling Order for Fentanyl-Related Substances, and for Other Purposes
- An Act to Amend the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act to Extend until October 2021, a Temporary Order for Fentanyl-Related Substances
- The opioid epidemic, a geography in two phases, David A. McGranahan and Timothy S. Parker
- Counterfeit pills fact sheet, fake prescription pills, widely available, increasingly lethal
- Halt All Lethal Trafficking of Fentanyl Act, report together with minority views (to accompany H.R. 467)
- Fighting fentanyl, the federal response to a growing crisis : hearing of the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining fighting fentanyl, focusing on the federal response to a growing crisis, July 26, 2022
- Carfentanil, a dangerous new factor in the U.S. opioid crisis
- The fentanyl crisis in America, inaction is no longer an option : hearing before the Subcommittee on Crime and Federal Government Surveillance of the Committee on the Judiciary, U.S. House of Representatives, One Hundred Eighteenth Congress, first session, Wednesday, March 1, 2023
- Clinical fentanyl testing, Amanda K. Sarata
- Limitations of CBP OFO's screening device used to identify fentanyl and other narcotics, Office of Inspector General
- Oversight of the Drug Enforcement Administration, hearing before the Subcommittee on Crime and Federal Government Surveillance of the Committee on the Judiciary, U.S. House of Representatives, One Hundred Eighteenth Congress, first session, Thursday, July 27, 2023
- An expiration date for temporary control of fentanyl analogues, Joanna R. Lampe
Outgoing Resources
- Focus1
- Sub focus1